SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc – ‘10-Q’ for 9/30/14 – ‘EX-10.2’

On:  Monday, 11/10/14, at 12:26pm ET   ·   For:  9/30/14   ·   Accession #:  731766-14-51   ·   File #:  1-10864

Previous ‘10-Q’:  ‘10-Q’ on 8/4/14 for 6/30/14   ·   Next:  ‘10-Q’ on 5/6/15 for 3/31/15   ·   Latest:  ‘10-Q’ on 11/6/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/10/14  Unitedhealth Group Inc            10-Q        9/30/14   69:16M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    839K 
 2: EX-10.1     Material Contract                                   HTML     29K 
 3: EX-10.2     Material Contract                                   HTML     25K 
 4: EX-12.1     Statement re: Computation of Ratios                 HTML     32K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     37K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
47: R1          Document and Entity Information Document            HTML     40K 
37: R2          Condensed Consolidated Balance Sheets               HTML    128K 
45: R3          Condensed Consolidated Balance Sheet                HTML     41K 
                (Parenthetical)                                                  
49: R4          Condensed Consolidated Statements of Operations     HTML     98K 
64: R5          Condensed Consolidated Statements of Comprehensive  HTML     61K 
                Income                                                           
39: R6          Condensed Consolidated Statements of Changes in     HTML     66K 
                Shareholders' Equity                                             
44: R7          Condensed Consolidated Statements of Cash Flows     HTML    119K 
33: R8          Basis of Presentation (Notes)                       HTML     35K 
25: R9          Investments (Notes)                                 HTML    286K 
65: R10         Fair Value (Notes)                                  HTML    326K 
51: R11         Medicare Part D Pharmacy Benefits (Notes)           HTML     40K 
50: R12         Medical Cost Reserve Development (Notes)            HTML     33K 
55: R13         Commercial Paper and Long-Term Debt (Notes)         HTML    168K 
56: R14         Shareholders' Equity (Notes)                        HTML     41K 
54: R15         Share-Based Compensation (Notes)                    HTML    105K 
57: R16         Commitments and Contingencies (Notes)               HTML     36K 
46: R17         Segment Financial Information (Notes)               HTML    321K 
48: R18         Basis of Presentation (Policies)                    HTML     34K 
53: R19         Investments (Tables)                                HTML    285K 
69: R20         Fair Value (Tables)                                 HTML    317K 
60: R21         Medicare Part D Pharmacy Benefits (Tables)          HTML     37K 
41: R22         Medical Cost Reserve Development (Tables)           HTML     34K 
52: R23         Commercial Paper and Long-Term Debt (Tables)        HTML    162K 
43: R24         Shareholders' Equity (Tables)                       HTML     30K 
19: R25         Share-Based Compensation (Tables)                   HTML    109K 
61: R26         Segment Financial Information (Tables)              HTML    315K 
66: R27         Basis of Presentation (Details)                     HTML     23K 
29: R28         Investments (Narrative) (Details)                   HTML     24K 
28: R29         Investments (Short-Term and Long-Term Investments)  HTML     80K 
                (Details)                                                        
31: R30         Investments (Fair Value of Mortgage-Backed          HTML     51K 
                Securities by Credit Rating Origination) (Details)               
32: R31         Investments (Amortized Cost and Fair Value of       HTML     64K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
34: R32         Investments (Amortized Cost and Fair Value of       HTML     52K 
                Held-To-Maturity Debt Securities by Contractual                  
                Maturity) (Details)                                              
18: R33         Investments (Fair Value of Available-For-Sale       HTML     57K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
58: R34         Investments (Net Realized Gains) (Details)          HTML     46K 
40: R35         Fair Value (Narrative) (Details)                    HTML     42K 
42: R36         Fair Value (Financial Assets and Liabilities,       HTML     74K 
                Excluding AARP, Measured at Fair Value on a                      
                Recurring Basis) (Details)                                       
22: R37         Fair Value (Financial Assets and Liabilities,       HTML     61K 
                Excluding AARP, Not Measured at Fair Value on a                  
                Recurring Basis) (Details)                                       
68: R38         Fair Value (Reconciliation of Assets Measured at    HTML     43K 
                Fair Value on a Recurring Basis Using Level 3                    
                Inputs) (Details)                                                
13: R39         Fair Value Fair Value Inputs Assets Quantitative    HTML     32K 
                Information (Details)                                            
35: R40         Fair Value (Assets and Liabilities measured at      HTML     87K 
                fair value on a recurring basis) (Details)                       
63: R41         Medicare Part D Pharmacy Benefits (Details)         HTML     26K 
21: R42         Medical Cost Reserve Development (Details)          HTML     26K 
27: R43         Commercial Paper and Long-Term Debt (Narrative)     HTML     61K 
                (Details)                                                        
30: R44         Commercial Paper and Long-Term Debt (Details)       HTML    112K 
38: R45         Shareholders' Equity (Details)                      HTML     33K 
17: R46         Shareholders' Equity Dividends Paid (Details)       HTML     27K 
24: R47         Share-Based Compensation (Stock Option and SAR      HTML     69K 
                Activity) (Details)                                              
14: R48         Share-Based Compensation (Restricted Share          HTML     38K 
                Activity) (Details)                                              
62: R49         Share-Based Compensation Other Share-Based          HTML     46K 
                Compensation Data (Details)                                      
20: R50         Share-Based Compensation (Share-Based Compensation  HTML     39K 
                Principal Fair Value Assumptions) (Details)                      
59: R51         Commitments and Contingencies (Details)             HTML     34K 
23: R52         Segment Financial Information (Narrative)           HTML     22K 
                (Details)                                                        
36: R53         Segment Financial Information (Details)             HTML     90K 
67: XML         IDEA XML File -- Filing Summary                      XML    100K 
15: EXCEL       IDEA Workbook of Financial Reports                  XLSX    285K 
26: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.90M 
 7: EX-101.INS  XBRL Instance -- unh-20140930                        XML   4.74M 
 9: EX-101.CAL  XBRL Calculations -- unh-20140930_cal                XML    211K 
10: EX-101.DEF  XBRL Definitions -- unh-20140930_def                 XML    778K 
11: EX-101.LAB  XBRL Labels -- unh-20140930_lab                      XML   1.66M 
12: EX-101.PRE  XBRL Presentations -- unh-20140930_pre               XML    964K 
 8: EX-101.SCH  XBRL Schema -- unh-20140930                          XSD    161K 
16: ZIP         XBRL Zipped Folder -- 0000731766-14-000051-xbrl      Zip    278K 


‘EX-10.2’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  UNH EX 10.2 9.30.2014  
Exhibit 10.2

FIFTH AMENDMENT
OF
UNITEDHEALTH GROUP
EXECUTIVE SAVINGS PLAN
(2004 Statement)


THIS AMENDMENT, made and entered into as of December 20, 2013, by UNITEDHEALTH GROUP INCORPORATED, a Minnesota corporation (“UnitedHealth Group”);
WHEREAS, UnitedHealth Group has established and maintains several nonqualified, deferred compensation programs (the “ESP”) for the benefit of a select group of management or highly compensated employees of UnitedHealth Group and certain affiliates of UnitedHealth Group; and
WHEREAS, said programs are currently embodied in a single document which is effective January 1, 2004, and which is entitled “UNITEDHEALTH GROUP EXECUTIVE SAVINGS PLAN (2004 Statement)” (hereinafter referred to as the “Plan Statement”); and
WHEREAS, the Board of Directors of UnitedHealth Group has delegated to the Compensation and Human Resources Committee of the Board of Directors the power and authority to amend the Plan Statement; and
WHEREAS, the Compensation and Human Resources Committee has further delegated its authority to amend the Plan Statement to the Executive Vice President, Human Capital with the exception of amendments that would materially increase the cost of the ESP, and amendments that are required to be adopted by the Board of Directors or the Compensation and Human Resources Committee in order to comply with the requirements of Section 162(m) of the Internal Revenue Code or Section 16 of the Securities Exchange Act of 1934; and
WHEREAS, the Executive Vice President, Human Capital wishes to amend the Plan Statement to provide that businesses in which UnitedHealth Group owns an interest of at least 50 percent will be treated as “Affiliates” for purposes of determining whether a Participant whose employment is transferred to such an entity has incurred a Separation from Service; and
WHEREAS, the Executive Vice President, Human Capital has determined that such amendments will not materially increase the cost of the ESP, and that none of such amendments are required to be adopted by the Board of Directors or the Compensation and Human Resources Committee in order to comply with the requirements of Section 162(m) of the Internal Revenue Code or Section 16 of the Securities Exchange Act of 1934.
NOW, THEREFORE, BE IT RESOLVED, that the Plan Statement is hereby amended in the following respect:
1.    DEFINITION OF AFFILIATES. Effective with respect to amounts deferred on and after January 1, 2014, Section 1.2.2 is amended to read as follows:


Exhibit 10.2

1.2.2. Affiliate -a business entity which is not an Employer but which is part of a “controlled group” with the Employer or under “common control” with an Employer, as those terms are defined in section 414(b) and (c) of the Code (applying an eighty percent (80%) common ownership standard except for purposes of determining whether a Participant has incurred a Separation from Service requiring a distribution of the portion of a Participant’s Account attributable to deferred base salary that would otherwise have been paid in 2014 or later, and deferred Incentive Awards and Performance Awards that would otherwise have been paid in 2015 or later, for which purpose a fifty percent (50%) common ownership standard shall be applied in accordance with Treasury Regulation §1.409A-1(h)(3)). A business entity which is a predecessor to an Employer shall be treated as an Affiliate if the Employer maintains a plan of such predecessor business entity or if, and to the extent that, such treatment is otherwise required by regulations under section 414(a) of the Code. A business entity shall also be treated as an Affiliate if, and to the extent that, such treatment is required by regulations under section 414(o) of the Code. In addition to said required treatment, the Executive Vice President, Human Capital may, in his or her discretion, designate as an Affiliate any business entity which is not such a “controlled group,” “common control” or “predecessor” business entity but which is otherwise affiliated with an Employer, subject to such limitations as the Executive Vice President, Human Capital may impose.
2.
SAVINGS CLAUSE. Save and except as hereinabove expressly amended, the Plan Statement shall continue in full force and effect.


- 2 -

Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/10/14None on these Dates
For Period end:9/30/14
1/1/14
12/20/13
1/1/04
 List all Filings 
Top
Filing Submission 0000731766-14-000051   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 12:31:33.1pm ET